Advocating for a cure for Herpes Simplex Virus.
Dr. Harvey Friedman is Professor of Medicine/Infectious Disease at University of Pennsylvania. Join to learn the latest on the BioNTech clinical trials. Recruiting for clinical trials in the US has begun - join to learn more about the research of Dr. Friedman and his team.
Alexander Birkman: Head of Research Dr. Hubert Trubel: Chief Medical Officer and Head of Clinical Development Pritelivir is currently in clinical trials in more than 70 locations globally.
Join Dr. TJ Cradick, Chief Scientific Officer at Excision Biotherapeutics to learn about Excision Bio pre-clinical work in gene therapy for Herpes Simplex. Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients. A recognized expert in genome editing technologies, Dr. Cradick has developed nucleases, as wellContinue reading "Dr. TJ Cradick: Excision Biotherapeutics"